Nference AI technology enables knowledge synthesis from unstructured text and structured biomedical databases. It synthesizes exponentially growing biomedical knowledge to solve urgent healthcare problems. The company uses state-of-the-art neural networks for real-time, automated extraction of insights by triangulating unstructured and structured information from the biomedical literature as well as from large scale molecular and real-world datasets. The platform enables a diverse set of applications ranging from R&D to commercial strategy and operations in the life sciences ecosystem.

Nference was founded in 2015 and is headquartered in Cambridge, Massachusetts.